Furthermore, multiple studies have shown PAX3-FOXO1 to be a substrate of GSK3β, inhibition of which reduces transcriptional activity of the fusion protein and proliferation of tumor cells in a PAX3-FOXO1 dependent manner [87, 88]. This evidence concerns the gene PAX3 and neoplasm.